IL6 and ovarian carcinoma: Colomiere et al. [36] indicated that EGFR-induced crosstalk with the IL-6R pathway may result in the acquisition of some EMT-associated phenotypes in ovarian cancer, although emphasis was placed on EGFR-mediated STAT3 activation, and the evidence for IL-6-induced EMT was incomplete.